Comparison between Dipna Pharmachem IPO and Rhetan TMT IPO.
Dipna Pharmachem IPO is a SME Fixed Price IPO proposed to list at BSE SME while Rhetan TMT IPO is a SME Fixed Price proposed to list at BSE SME.
| Dipna Pharmachem IPO | Rhetan TMT IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Aryaman Financial Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Sernet Financial Services Pvt.Ltd. | Aryaman Capital Markets Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Dipna Pharmachem IPO is up to ₹14.43 Cr whereas the issue size of the Rhetan TMT IPO is up to ₹53.09 Cr. The final issue price of Dipna Pharmachem IPO is ₹38.00 per share and of Rhetan TMT IPO is ₹70.00 per share.
| Dipna Pharmachem IPO | Rhetan TMT IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹38.00 per share | ₹70.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 2000 shares |
| Fresh Issue Size | 37,98,000 shares | 75,84,000 shares |
| Fresh Issue Size (Amount) | up to ₹14.43 Cr | up to ₹53.09 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 37,98,000 shares | 75,84,000 shares |
| Issue Size Total (Amount) | up to ₹14.43 Cr | up to ₹53.09 Cr |
Dipna Pharmachem IPO opens on Aug 25, 2022, while Rhetan TMT IPO opens on Aug 22, 2022. The closing date of Dipna Pharmachem IPO and Rhetan TMT IPO is Aug 30, 2022, and Aug 25, 2022, respectively.
| Dipna Pharmachem IPO | Rhetan TMT IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 25, 2022 | Aug 22, 2022 |
| Issue Close | Aug 30, 2022 | Aug 25, 2022 |
| Basis Of Allotment (Tentative) | Aug 30, 2022 | |
| Initiation of Refunds (Tentative) | Sep 01, 2022 | |
| Credit of Share (Tentative) | Sep 02, 2022 | |
| Listing date (Tentative) | Sep 08, 2022 | Sep 05, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Dipna Pharmachem IPO P/E ratio is 39, as compared to Rhetan TMT IPO P/E ratio of 63.64.
| Dipna Pharmachem IPO | Rhetan TMT IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 99.62 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.56 | 62.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 39 | 63.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹45.49 Cr. | ₹148.75 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹333.40 | ₹2.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 67.12 | 10.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Dipna Pharmachem IPO Retail Individual Investors (RII) are offered 18,99,000 shares while in Rhetan TMT IPO retail investors are offered 18,99,000 shares. Qualified Institutional Buyers (QIB) are offered in Dipna Pharmachem IPO and in Rhetan TMT IPO.
| Dipna Pharmachem IPO | Rhetan TMT IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 2,04,000 shares | 4,16,000 shares |
| QIB | ||
| NII | 18,99,000 shares | 37,92,000 shares |
| RII | 18,99,000 shares | 37,92,000 shares |
| Employee | ||
| Others | ||
| Total | 37,98,000 shares | 75,84,000 shares |
Dipna Pharmachem IPO subscribed 2.77x in total, whereas Rhetan TMT IPO subscribed 1.47x.
| Dipna Pharmachem IPO | Rhetan TMT IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 0.78x | 2.18x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.75x | 0.76x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.77x | 1.47x |
